SPIRIT for Persons With Dementia and Complex Multimorbidity

NACompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

February 14, 2020

Primary Completion Date

March 24, 2022

Study Completion Date

March 23, 2023

Conditions
End Stage Renal Disease
Interventions
BEHAVIORAL

SPIRIT-Dementia

"The interventionist will begin the SPIRIT-dementia session by assessing the patient's and surrogate's cognitive, emotional, and spiritual/religious representations of the patient's illness, prognosis, and end-of-life care. Individualized information will be provided about the effectiveness of life-sustaining treatment for people with end-organ failure, and the patient will examine their values about life-sustaining treatment at the end of life. The interventionist will help the surrogate prepare for end-of-life decision-making and for the emotional burden of decision-making. A Goals-of-Care document will be completed at the end of the session. The delivery of SPIRIT-dementia incorporates enhanced consent techniques, such as reducing information load by proceeding in manageable segments, offering repetition of material, opportunity for rehearsal, and using targeted questioning to verify adequate comprehension prior to eliciting preferences for goals of care."

BEHAVIORAL

Usual Care

As required by Centers for Medicare and Medicaid Services (CMS) written information on advance directives is provided to a patient on the first day of dialysis, and a social worker reviews this information with patients and encourages them to complete an advance directive.

Trial Locations (4)

30033

Emory Dialysis at North Decatur, Decatur

30034

Emory Dialysis at Candler, Decatur

30318

Emory Dialysis at Northside, Atlanta

30331

Emory Dialysis at Greenbriar, Atlanta

All Listed Sponsors
collaborator

National Institute of Nursing Research (NINR)

NIH

collaborator

National Institute on Aging (NIA)

NIH

lead

Emory University

OTHER

NCT04108000 - SPIRIT for Persons With Dementia and Complex Multimorbidity | Biotech Hunter | Biotech Hunter